ESTRO 2024 - Abstract Book

S1595

Clinical - Lung

ESTRO 2024

Conclusion:

Higher levels of MIP-1b, CCL-17, IL- 1α, and lower level of Tie -2 before PCI might be associated with subsequent neurocognitive decline. Decreasing of VEGF-C, CCL-17, IL-1a,and VEGF 3-days after initiating PCI might indicate higher risks for developing neurocognitive decline after 4-months. If validated, these biomarkers could be used in decision aid tools to predict the risk of neurocognitive decline.

Keywords: cognitive decline, biomarkers